 National, multicenter, open label single-arm, non-comparative study, that will evaluate the MTD and the efficacy of the Kinesin Spindle Protein KSP inhibitor Filanesib ARRY-520 in combination with pomalidomide dexamethasone in relapsed or refractory MM patients. 